Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
about
Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in micemiRNAs Participate in MS Pathological Processes and Its Therapeutic ResponseRegulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAsPotential function of miRNAs in herpetic stromal keratitisThe genetics of multiple sclerosis: review of current and emerging candidatesMicroRNA regulation of lymphocyte tolerance and autoimmunityIntegrating non-coding RNAs in JAK-STAT regulatory networksMicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and developmentMicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular SpecificityTargeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.The IL-23-IL-17 immune axis: from mechanisms to therapeutic testingncRNA-regulated immune response and its role in inflammatory lung diseasesCirculating microRNAs as biomarkers for disease staging in multiple sclerosisA multi-targeted approach to suppress tumor-promoting inflammationIn vivo inhibition of miR-155 significantly alters post-stroke inflammatory responseMicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic diseaseMicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitisIdentification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia.Expression, regulation and function of microRNAs in multiple sclerosismiR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression.Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury.Elevated levels of miR-155 in blood and urine from patients with nephrolithiasis.miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme.Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes.Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathyMicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1Heterogeneity of oligodendrocyte progenitor cells in adult human brainTranscriptional and epigenetic networks of helper T and innate lymphoid cells.MicroRNAs: new players in IBD.Role of miR-155 in the pathogenesis of herpetic stromal keratitis.Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases.A Novel Transgenic Mouse Line for Tracing MicroRNA-155-5p Activity In Vivo.MicroRNA-155 Reinforces HIV Latency.Genetic association and altered gene expression of mir-155 in multiple sclerosis patients.Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.A Single miRNA-mRNA Interaction Affects the Immune Response in a Context- and Cell-Type-Specific Manner.MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophagesIn Vivo Inhibition of miR-155 Promotes Recovery after Experimental Mouse Stroke
P2860
Q21559575-7AE86231-A468-4A29-AF9B-6FE352A09A1CQ26748774-A7D39AA9-23F1-4D9F-9AB2-8AF56382C81AQ26799975-16636B15-EDA0-4133-8382-6B57825B67ADQ26823201-030AB3D5-5525-4EF7-9E41-3C41D97CF43DQ26825782-605ED48F-9CED-4127-BF4E-0B8EF0CBF538Q26852975-CDDC91B9-F24C-4333-BE89-9916FBFA8988Q26863279-B44272EE-6519-44E8-A71E-F048BBAEDF40Q27003271-BD5957FD-8CAA-4D10-B2F3-C97E6B644BEBQ27335229-1E6BE6F4-DE17-44EE-A527-878826CC042FQ27340206-5E339C0F-9A1B-4522-A4B9-12D6B731AB23Q27687800-9CC4E487-8A44-4BAD-9D46-959328FC664EQ28082698-14B3D12D-9ABB-44EA-A02A-5AB1851D8B8EQ28287246-75F3B569-8FB3-4E02-A45A-C48080CDD5F7Q28393278-44EF5E76-4ED1-441C-8568-7D93D2248C29Q28595988-70D1EE46-6738-4AFF-9BCC-E1F4BF64DAF6Q28596130-4DEC843D-9B7D-48BD-A7B2-033C3732283DQ28975627-361BA5A9-F128-49EE-95F0-A3CCB65D1C39Q30667392-67F51FFD-3E56-47BA-AA13-BA0790A2B6CCQ31144077-0445C7B7-5287-4D92-9CFB-FB4D721E0A03Q33754662-7C8E0259-13DC-4C9D-B26C-78D81AAC03BBQ33882867-42850209-5B79-4EE5-8F99-136B5E79A9D8Q33899715-C717518F-24C5-45FD-87D2-79BBC24946D7Q34114226-5C9DF843-3273-4EE3-BFA8-0F1E54BE3549Q34354883-47F839D4-621F-499D-B6A1-9D1FF2C7F9BEQ34355656-A50D9213-487B-4ED5-AFA0-F2009ABD75C2Q34356521-3EDC3496-3CF0-4FD9-9C92-CCE445C5C409Q34359754-021FE5F9-F6B2-4974-B187-A75804653563Q34455072-DE45466E-1C41-4899-8BD6-6036A4AC2BC0Q34936700-846023BF-43E0-44D9-8727-53B362823FE0Q35064355-7AF34912-CEA5-4DEB-9269-DF107E867BA2Q35135542-4DED0102-4D16-448A-8081-9F685976EF71Q35236558-E9F9C9EF-E7E4-4DBB-8D02-A500BDFEC620Q35619546-502BB899-D1A4-4141-9AC3-DE7B1E901715Q35647942-4D8826F6-B6C9-45D9-8558-7E167E5769E6Q35662247-3D4024E5-91D3-4AA1-96D5-B6027CD5E590Q35669464-CEB20AB7-EA52-4140-A232-7FF3493CAFC6Q35869551-D1940255-B9C2-4BB9-B7F8-7D44BAD8C660Q35930311-4D28E7B7-511D-4459-928F-03D9E13D75D8Q36023315-C3D8703C-30DF-4A2D-A705-E7010E61DA79Q36038242-BC24D564-C292-4C33-A6EF-149BC5A99CEC
P2860
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
@ast
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
@en
type
label
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
@ast
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
@en
prefLabel
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
@ast
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
@en
P2093
P2860
P356
P1476
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.
@en
P2093
Akanksha Mittal
Gopal Murugaiyan
Nicole Joller
Vanessa Beynon
P2860
P304
P356
10.4049/JIMMUNOL.1003952
P407
P577
2011-07-25T00:00:00Z